HNGE logo

HNGE Hinge Health, Inc.

New York Stock Exchange · Medical - Healthcare Information Services · Healthcare

$88.49
+1.07 (+1.22%)

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company p…

Market Cap: $6.85Bwww.hingehealth.com

Price (90d)

$86.32
$48.89$63.12$77.34$91.57
May 4Aug 12

Signal Score (90d)

70
70100130160
Aug 10Aug 14

Quote

Day Range
$86.16 – $88.89
52-Week Range
$30.08 – $93.13
Volume
$1.05M
Market Cap
$6.85B
50-Day Avg
$78.48
200-Day Avg
$53.51
Prev Close
$87.42
Open
$87.75

Valuation & Ratios

P/E Ratio
-8.67
EPS
$-6.67
P/B Ratio
9.72
P/S Ratio
6.26
Debt/Equity
0.02
Current Ratio
1.47
Dividend Yield
+0.0%
Gross Margin
+79.8%

Returns & Efficiency

Return on Equity
-139.6%
Return on Assets
-70.9%
FCF Yield
+4.6%
EV/EBITDA
-6.49

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$587.86M$-528.26M$-5.36
2024$390.40M$-11.93M$-0.15
2023$292.73M$-108.14M$-1.39

Social Signal Score

65
5d
64
6 mentions
-5.7%
30d
65
7 mentions
+0.4%
60d
65
7 mentions
+27.3%
90d
65
7 mentions
+58.4%
news: 7

Earnings

Tue, Nov 3(in 3 months)

Consensus estimate $0.61 per share

5of 6 quarters beat consensus

Typical surprise +94.3% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 4$0.59 vs $0.61miss
  • Tue, May 5$0.45 vs $0.39beat
  • Tue, Feb 10$0.49 vs $0.04beat
  • Tue, Nov 4$0.34 vs $0.24beat
  • Tue, Aug 5$0.67 vs $0.09beat
  • Mon, May 5$0.21 vs $0.09beat

Estimates and results for HNGE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

HNGEhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (7)

  • Newszacks.com·1d ago·Positive

    Reasons to Hold Hinge Health Stock in Your Portfolio for Now HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

    View source ↗
  • Newszacks.com·3d ago·Positive

    Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise? HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.

    View source ↗
  • Newszacks.com·3d ago·Neutral

    Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.

    View source ↗
  • Newszacks.com·3d ago·Positive

    HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.

    View source ↗
  • Newszacks.com·3d ago·Negative

    Is the Options Market Predicting a Spike in Hinge Health Stock? Investors need to pay close attention to HNGE stock based on the movements in the options market lately.

    View source ↗
  • Newsbenzinga.com·3d ago·Positive

    Jim Cramer Recommends Buying This Health Care Stock: ‘What A Quarter They Had' On CNBC's “Mad Money Lightning Round,” Jim Cramer said Hinge Health, Inc. (NYSE:HNGE) is a buy. “What a quarter they had,” he added.

    View source ↗
  • Newszacks.com·5d ago·Positive

    Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

    View source ↗